Technology | May 15, 2015

Application highlights evidence-based treatment options at the point of care

McKesson Specialty Health, Guideline Explorer, cancer, iPad, Clear Value Plus

May 15, 2015 — McKesson Specialty Health announced the availability of Clear Value Plus – Guideline Explorer to iPad users. The Guideline Explorer app is a mobile reference tool that gives users access to evidence-based cancer protocols based on patient attributes.

Available for download on the Apple App Store at no cost, the Guideline Explorer app provides users with an easy-to-use interface for exploring patient-specific treatment options based on the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) and Value Pathways powered by NCCN. Current Clear Value Plus users can access the complete range of evidence-based treatment options and see all treatment choices that are highlighted as part of the Value Pathways powered by NCCN. New iPad users can navigate NCCN Content and explore chemotherapy regimens based on specific patient characteristics and quickly view up-to-date chemotherapy options, as well as known side effect profiles.

The new iPad tool is an extension of McKesson Specialty Health’s Clear Value Plus, a quality support tool for oncologists that highlights evidence-based treatment options at the point of care. The software brings to life Value Pathways powered by NCCN and NCCN Guidelines within the clinical workflow—offering evidence-based protocols at the point of care with the patient. In addition, Clear Value Plus is compatible with multiple provider systems and provides integrated financial information, real-time reporting and benchmarking to demonstrate the value of delivering evidence-based care.

For more information: www.mckessonspecialtyhealth.com


Related Content

News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
Subscribe Now